Covering IPOs, Healthcare and Technology Stocks

Andrei Zakharov

Algosun Global

Private Capital Markets

MegaRobo Technologies / Private Capital Markets

<ul>
<li>MegaRobo is a leader in life science automation, founded in 2016 by CEO Daniel Huang and CMO Zhixin Qiao. The company reached a unicorn valuation of $1B+ in 2022. </li>
<li>MegaRobo wants to improve the efficiency of life sciences research by using robotics and AI technology. In June 2022, AI and robotics unicorn closed the $300M Series C round.    </li>
<li>Using AI in R&amp;D drug discovery is gaining traction. The global lab automation market is a ~$5B opportunity and is expected to reach ~$9.4B by 2030. </li>
</ul>


MegaRobo is a leader in life science automation, founded in 2016 by CEO Daniel Huang and CMO Zhixin Qiao. The company reached a unicorn valuation of $1B+ in 2022. 
MegaRobo wants to improve the efficiency of life sciences research by using robotics and AI technology. In June 2022, AI and robotics unicorn closed the $300M Series C round.    
Using AI in R&amp;D drug discovery is gaining traction. The global lab automation market is a ~$5B opportunity and is expected to reach ~$9.4B by 2030. 


MegaRobo: China-Based Disruptor in Life Science Automation

China

MegaRobo Technologies Co., Ltd. develops robots. The company focuses on providing lightweight intelligent collaborative robots and automation solutions. MegaRobo Technologies also provides maintenance services.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

MegaRobo Technologies (1655273D CH)

MegaRobo: China-Based Disruptor in Life Science Automation

VC-backed MegaRobo is uniquely positioned to benefit from the growth of both the life science automation market as well as AI healthcare market. We...

Andrei Zakharov

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)